We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Level up your trading with our powerful tools and real-time insights all in one place.
The current SNGX market cap is 44M. The company's latest EPS is USD -0.5917 and P/E is -6.93.
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 257k | 207k | 131k | 244k | 117k |
| Operating Income | -2.15M | -1.63M | -1.78M | -2.14M | -2.12M |
| Net Income | -1.05M | -1.61M | -1.66M | -1.82M | -1.92M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 4.63M | 2.36M | 824k | 949k | 839k |
| Operating Income | -10.54M | -18.59M | -13.14M | -14.24M | -7.7M |
| Net Income | -9.36M | -17.69M | -12.55M | -13.8M | -6.14M |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 11.1M | 13.83M | 11.3M | 9.8M | 8.06M |
| Total Liabilities | 14.49M | 8.03M | 7.08M | 7.28M | 7.29M |
| Total Equity | -3.39M | 5.8M | 4.22M | 2.52M | 768k |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 7.78M | 19.89M | 26.87M | 14.28M | 9.8M |
| Total Liabilities | 6.32M | 16.15M | 16.15M | 16.75M | 7.28M |
| Total Equity | 1.46M | 3.74M | 10.72M | -2.47M | 2.52M |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -2.17M | -4.09M | -6.78M | -8.6M | -1.34M |
| Investing | N/A | N/A | N/A | N/A | N/A |
| Financing | -932k | 3.88M | 3.71M | 3.66M | -9k |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -7.51M | -11.46M | -11.74M | -12.65M | -8.6M |
| Investing | -24k | -7k | -12k | -13k | N/A |
| Financing | 4.01M | 24.68M | 19.06M | 77k | 3.66M |
| Market Cap | 44M |
| Price to Earnings Ratio | -6.93 |
| Price to Sales Ratio | 50.74 |
| Price to Cash Ratio | 5.04 |
| Price to Book Ratio | 16.87 |
| Dividend Yield | - |
| Shares Outstanding | 10.38M |
| Average Volume (1 week) | 187.88k |
| Average Volume (1 Month) | 325.78k |
| 52 Week Change | -62.14% |
| 52 Week High | 32.00 |
| 52 Week Low | 3.30 |
| Spread (Intraday) | 0.29 (6.9%) |
| Company Name | Soligenix Inc |
| Address |
3411 silverside road tatnall wilmington, delaware 19810 |
| Website | https://www.soligenix.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
